Antihypertensive Efficacy Of Nebivolol And Low Dose Spironolactone In Patients With Resistant Hypertension
CONCLUSION: Nebivolol is an effective treatment option for resistant hypertension and the antihypertensive effect of nebivolol is similar to low-dose spironolactone.PMID:37671517 | DOI:10.5543/tkda.2023.60464 (Source: Turk Kardiyoloji Dernegi arsivi)
Source: Turk Kardiyoloji Dernegi arsivi - September 6, 2023 Category: Cardiology Authors: Hamdi P üşüroğlu Ender Özal Ahmet Ya şar Çizgici Yal çın Avcı Ali R ıza Demir İsmail Bıyık Source Type: research

Antihypertensive Efficacy Of Nebivolol And Low Dose Spironolactone In Patients With Resistant Hypertension
CONCLUSION: Nebivolol is an effective treatment option for resistant hypertension and the antihypertensive effect of nebivolol is similar to low-dose spironolactone.PMID:37671517 | DOI:10.5543/tkda.2023.60464 (Source: Turk Kardiyoloji Dernegi arsivi)
Source: Turk Kardiyoloji Dernegi arsivi - September 6, 2023 Category: Cardiology Authors: Hamdi P üşüroğlu Ender Özal Ahmet Ya şar Çizgici Yal çın Avcı Ali R ıza Demir İsmail Bıyık Source Type: research

Antihypertensive Efficacy Of Nebivolol And Low Dose Spironolactone In Patients With Resistant Hypertension
CONCLUSION: Nebivolol is an effective treatment option for resistant hypertension and the antihypertensive effect of nebivolol is similar to low-dose spironolactone.PMID:37671517 | DOI:10.5543/tkda.2023.60464 (Source: Turk Kardiyoloji Dernegi arsivi)
Source: Turk Kardiyoloji Dernegi arsivi - September 6, 2023 Category: Cardiology Authors: Hamdi P üşüroğlu Ender Özal Ahmet Ya şar Çizgici Yal çın Avcı Ali R ıza Demir İsmail Bıyık Source Type: research

Antihypertensive Efficacy Of Nebivolol And Low Dose Spironolactone In Patients With Resistant Hypertension
CONCLUSION: Nebivolol is an effective treatment option for resistant hypertension and the antihypertensive effect of nebivolol is similar to low-dose spironolactone.PMID:37671517 | DOI:10.5543/tkda.2023.60464 (Source: Turk Kardiyoloji Dernegi arsivi)
Source: Turk Kardiyoloji Dernegi arsivi - September 6, 2023 Category: Cardiology Authors: Hamdi P üşüroğlu Ender Özal Ahmet Ya şar Çizgici Yal çın Avcı Ali R ıza Demir İsmail Bıyık Source Type: research

Antihypertensive Efficacy Of Nebivolol And Low Dose Spironolactone In Patients With Resistant Hypertension
CONCLUSION: Nebivolol is an effective treatment option for resistant hypertension and the antihypertensive effect of nebivolol is similar to low-dose spironolactone.PMID:37671517 | DOI:10.5543/tkda.2023.60464 (Source: Turk Kardiyoloji Dernegi arsivi)
Source: Turk Kardiyoloji Dernegi arsivi - September 6, 2023 Category: Cardiology Authors: Hamdi P üşüroğlu Ender Özal Ahmet Ya şar Çizgici Yal çın Avcı Ali R ıza Demir İsmail Bıyık Source Type: research

Antihypertensive Efficacy Of Nebivolol And Low Dose Spironolactone In Patients With Resistant Hypertension
CONCLUSION: Nebivolol is an effective treatment option for resistant hypertension and the antihypertensive effect of nebivolol is similar to low-dose spironolactone.PMID:37671517 | DOI:10.5543/tkda.2023.60464 (Source: Turk Kardiyoloji Dernegi arsivi)
Source: Turk Kardiyoloji Dernegi arsivi - September 6, 2023 Category: Cardiology Authors: Hamdi P üşüroğlu Ender Özal Ahmet Ya şar Çizgici Yal çın Avcı Ali R ıza Demir İsmail Bıyık Source Type: research

Antihypertensive Efficacy Of Nebivolol And Low Dose Spironolactone In Patients With Resistant Hypertension
CONCLUSION: Nebivolol is an effective treatment option for resistant hypertension and the antihypertensive effect of nebivolol is similar to low-dose spironolactone.PMID:37671517 | DOI:10.5543/tkda.2023.60464 (Source: Turk Kardiyoloji Dernegi arsivi)
Source: Turk Kardiyoloji Dernegi arsivi - September 6, 2023 Category: Cardiology Authors: Hamdi P üşüroğlu Ender Özal Ahmet Ya şar Çizgici Yal çın Avcı Ali R ıza Demir İsmail Bıyık Source Type: research

Antihypertensive Efficacy Of Nebivolol And Low Dose Spironolactone In Patients With Resistant Hypertension
CONCLUSION: Nebivolol is an effective treatment option for resistant hypertension and the antihypertensive effect of nebivolol is similar to low-dose spironolactone.PMID:37671517 | DOI:10.5543/tkda.2023.60464 (Source: Turk Kardiyoloji Dernegi arsivi)
Source: Turk Kardiyoloji Dernegi arsivi - September 6, 2023 Category: Cardiology Authors: Hamdi P üşüroğlu Ender Özal Ahmet Ya şar Çizgici Yal çın Avcı Ali R ıza Demir İsmail Bıyık Source Type: research

Antihypertensive Efficacy Of Nebivolol And Low Dose Spironolactone In Patients With Resistant Hypertension
CONCLUSION: Nebivolol is an effective treatment option for resistant hypertension and the antihypertensive effect of nebivolol is similar to low-dose spironolactone.PMID:37671517 | DOI:10.5543/tkda.2023.60464 (Source: Turk Kardiyoloji Dernegi arsivi)
Source: Turk Kardiyoloji Dernegi arsivi - September 6, 2023 Category: Cardiology Authors: Hamdi P üşüroğlu Ender Özal Ahmet Ya şar Çizgici Yal çın Avcı Ali R ıza Demir İsmail Bıyık Source Type: research

Antihypertensive Efficacy Of Nebivolol And Low Dose Spironolactone In Patients With Resistant Hypertension
CONCLUSION: Nebivolol is an effective treatment option for resistant hypertension and the antihypertensive effect of nebivolol is similar to low-dose spironolactone.PMID:37671517 | DOI:10.5543/tkda.2023.60464 (Source: Turk Kardiyoloji Dernegi arsivi)
Source: Turk Kardiyoloji Dernegi arsivi - September 6, 2023 Category: Cardiology Authors: Hamdi P üşüroğlu Ender Özal Ahmet Ya şar Çizgici Yal çın Avcı Ali R ıza Demir İsmail Bıyık Source Type: research

Antihypertensive Efficacy Of Nebivolol And Low Dose Spironolactone In Patients With Resistant Hypertension
CONCLUSION: Nebivolol is an effective treatment option for resistant hypertension and the antihypertensive effect of nebivolol is similar to low-dose spironolactone.PMID:37671517 | DOI:10.5543/tkda.2023.60464 (Source: Turk Kardiyoloji Dernegi arsivi)
Source: Turk Kardiyoloji Dernegi arsivi - September 6, 2023 Category: Cardiology Authors: Hamdi P üşüroğlu Ender Özal Ahmet Ya şar Çizgici Yal çın Avcı Ali R ıza Demir İsmail Bıyık Source Type: research

Antihypertensive Efficacy Of Nebivolol And Low Dose Spironolactone In Patients With Resistant Hypertension
CONCLUSION: Nebivolol is an effective treatment option for resistant hypertension and the antihypertensive effect of nebivolol is similar to low-dose spironolactone.PMID:37671517 | DOI:10.5543/tkda.2023.60464 (Source: Turk Kardiyoloji Dernegi arsivi)
Source: Turk Kardiyoloji Dernegi arsivi - September 6, 2023 Category: Cardiology Authors: Hamdi P üşüroğlu Ender Özal Ahmet Ya şar Çizgici Yal çın Avcı Ali R ıza Demir İsmail Bıyık Source Type: research

Antihypertensive Efficacy Of Nebivolol And Low Dose Spironolactone In Patients With Resistant Hypertension
CONCLUSION: Nebivolol is an effective treatment option for resistant hypertension and the antihypertensive effect of nebivolol is similar to low-dose spironolactone.PMID:37671517 | DOI:10.5543/tkda.2023.60464 (Source: Turk Kardiyoloji Dernegi arsivi)
Source: Turk Kardiyoloji Dernegi arsivi - September 6, 2023 Category: Cardiology Authors: Hamdi P üşüroğlu Ender Özal Ahmet Ya şar Çizgici Yal çın Avcı Ali R ıza Demir İsmail Bıyık Source Type: research

Pharmaco ‐disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries
ConclusionsThere was marked variation between countries in the retail price of HFrEF GDMT. Despite higher prices in high-income countries, GDMT was more accessible and affordable than in low- and middle-income countries. Publicly funded drug programmes in lower income countries increased affordability but limited access to newer HFrEF GDMT classes. Pharmaco-disparities must be addressed to improve HFrEF outcomes globally. (Source: ESC Heart Failure)
Source: ESC Heart Failure - August 30, 2023 Category: Cardiology Authors: Tauben Averbuch, Meisam Esfahani, Rani Khatib, James Kayima, Juan Jaime Miranda, Rishi K. Wadhera, Faiez Zannad, Ambarish Pandey, Harriette G. C. Van Spall Tags: Original Article Source Type: research

GSE200313 Exploiting crosstalk between glucocorticoid and mineralocorticoid receptors enhances glucocorticoid-induced killing of multiple myeloma cells
Contributors : Dorien Clarisse ; Philip Vlummens ; Karlien Van Wesemael ; Jonathan Thommis ; Daria Fijalkowska ; Guillaume Acke ; lse M Beck ; Fritz Offner ; Karolien De BosscherSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensLong-term glucocorticoid treatment in multiple myeloma is hampered by deleterious side effects. Glucocorticoids bind to the glucocorticoid receptor (GR), which is a crucial drug target because its activation triggers myeloma cell death. The mineralocorticoid receptor (MR) is a closely related nuclear receptor but its impact on glucocorticoid responsivenes...
Source: GEO: Gene Expression Omnibus - August 23, 2023 Category: Genetics & Stem Cells Tags: Expression profiling by high throughput sequencing Homo sapiens Source Type: research